Screening of inFlammation to enable personalized Medicine
Together we reach the next level of diagnostics
Millions of people in the European Union suffer from diseases associated with dysregulation of the complement system, which is a major component of
the immune system.
-
approximately 3,300 new cases of bacterial infections such as invasive meningococcal disease are diagnosed per year in infants and young children in the EU
-
about 200,000 young adults in Europe suffer from chronic inflammation of the kidney
-
15 million elderly European residents are affected by limited vision due to age-related macular degeneration.
Learn more
SciFiMed will
-
investigate the pathophysiology of the FH-protein family,
to enable
-
the development of personalized, radically new on-time diagnostics,
which allow
-
improved patient stratification for prospective cohort studies
to -
understand complement-associated diseases.
SciFiMed is a multi-disciplinary project and will combine fundamental immunological research with novel nanomaterial-based biosensor development translated into proof-of-principle diagnostics.
SciFiMed will revolutionize doctors’ ability to diagnose and treat severe inflammatory diseases plaguing millions of Europeans.